2023 Annual Report of Metabolism and Target Organ Damage (M&TOD)
The year 2023 marked significant milestones for Metabolism and Target Organ Damage (M&TOD), signifying a pivotal phase in the journal's development. Under the guidance of Editor-in-Chief Prof. Amedeo Lonardo and with substantial support from our dedicated Editorial Board members, the journal achieved notable progress.
Noteworthy Highlights of 2023:
1. Editorial Board
In 2023, we welcomed 11 outstanding scholars to the Editorial Board, significantly enriching the diversity and expertise of the journal. As of December 31, 2023, the Editorial Board consists of 68 members from 14 countries. Special recognition was accorded to Dr. Juan Pablo Arab, Dr. Fernando Bril, and Prof. Alessandro Mantovani, who were elevated from Youth Editorial Board members to Editorial Board members for their substantial support and ongoing contributions to M&TOD.
2. Authorship
Contributors to M&TOD in 2023 hailed from 22 countries and regions, including the United States, Italy, India, China, Turkey, the United Kingdom, Mexico, South Korea, Brazil, Australia, Greece, Lebanon, Sweden, Chile, Belgium, Portugal, and others. Notably, there was a significant increase in authors from the United States compared to the previous year, indicating the journal's expanding reach and engagement within the United States scholarly community.
3. Readership
The development and growth of M&TOD led to a surge in readership, with attention from an escalating number of readers worldwide. The journal's reach expanded from 127 countries/regions last year to an impressive 148 countries/regions, highlighting its ever-growing global impact and resonance. This international reach spanned nations/regions such as the United States, China, India, United Kingdom, Netherlands, Italy, Australia, Finland, Canada, France, Japan, South Korea, Germany, Hong Kong, and Sweden, among others.
4. Articles
Throughout 2023, with a rejection rate of 61%, the journal published a total of 23 articles, encompassing 13 Reviews, 3 Commentaries, 1 Original Article, 1 Case Report, 1 Opinion, 1 Perspective, and 3 Editorials. These contributions garnered 107 citations in 2023 (according to Google Scholar), marking a significant increase from the previous year.
5. Special Issues
As M&TOD’s readership and global influence grows, more and more renowned experts show interest in setting up Special Issues, contributing to the development of the journal. In 2023, M&TOD successfully launched 13 Special Issues, each dedicated to diverse hot topics. These Special Issues attracted active participation from hundreds of experts across various domains.
(1) Metabolic and Bariatric Surgery: Current Situation and Future Challenges
Guest Editors: Dr. Ken Loi from University of NSW, Sydney, Australia (passed away) and Dr. Wah Yang from the First Affiliated Hospital of Jinan University, China. Here’s wishing Dr. Ken Loi rest in peace.
(2) Regulation of Lipid and Lipoproteins Metabolism in Health and Disease
Guest Editor: Dr. Andrea Baragetti from University of Milan, Italy.
(3) Metabolic Bone Disease: From Basic Science to Clinical Frontier
Guest Editor: Prof. Lingfeng Zeng from Guangdong Provincial Academy of Chinese Medical Science, China.
(4) The Latest Research Progress of Non-Alcoholic Fatty Liver Disease
Guest Editor: Dr. Stefano Ballestri from Hospital of Pavullo, Italy.
(5) Genetics of Diabetes and New Therapies for Diabetes
Guest Editor: Dr. Thinzar Min and Prof. Stephen C Bain from Swansea University Medical School, Swansea, UK.
(6) Emerging Insights into Metabolic Neuropathies: From Pathogenesis to Clinical Management
Guest Editor: Dr. Shazli Azmi from Manchester University NHS Foundation Trust, UK.
(7) Advances in Research on Skin Metabolism
Guest Editor: Prof. Maibach Howard from University of California, USA and Dr. Sung Min Pyo from Freie Universität Berlin, Germany.
(8) Adipose Tissue and Metabolism in Chronic Diseases
Guest Editor: Dr. Angelo Di Vincenzo and Prof. Marco Rossato from University Hospital of Padova, Italy.
(9) Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Guest Editor: Dr. Mariana Verdelho Machado from Hospital de Vila Franca de Xira, Portugal.
(10) Skeletal Muscle Metabolism: Regulation, Adaptation, and Health
Guest Editor: Dr. Tatiana Y Kostrominova from Indiana University School of Medicine Northwest, Indianapolis, USA.
(11) Progress in Disease-Modifying Therapies for Type 1 Diabetes Mellitus
Guest Editor: Dr. Marco Infante from Saint Camillus International University of Health Sciences, Italy.
(12) Liver Transplantation for alcohol and metabolic associated steatotic liver disease
Guest Editor: Prof. Ashwani K. Singal from University of South Dakota Sanford School of Medicine, USA.
(13) Altered Metabolism in Hepatic Injury
Guest Editor: Dr. Sonia Michael Najjar from Ohio University, USA.
6. Webinars
M&TOD organized two impactful webinars centered around diverse and trending topics that drew a massive online audience. These sessions fostered stimulating discussions and facilitated enriching dialogues among the participating experts. The positive atmosphere and engaging discussions attracted scholars from different countries who devoted their time and resources to participate, making the webinar a great success. M&TOD aims to offer a communication platform for scholars in this field and looks forward to inviting more well-experienced experts and enthusiastic young scholars to participate in future webinars.
Webinar Topics and Chairs:
(1) The Complications of Diabetes
Chair: Prof. Ketan Dhatariya from Norwich Medical School, University of East Anglia, UK.
(2) Future Research Priorities in Metabolic and Bariatric Surgery
Chair: Dr. Wah Yang from the First Affiliated Hospital of Jinan University, China.
7. Interviews
(1) Dr. Juan Pablo Arab from Western University, Canada.
(2) Prof. Ashwani K. Singal from University of South Dakota Sanford School of Medicine, USA.
(3) Dr. Mariana Verdelho Machado from Hospital de Vila Franca de Xira in Lisbon, Portugal.
(4) Dr. Tatiana Y. Kostrominova from Indiana University School of Medicine Northwest, USA.
(5) Dr. Fernando Bril from University of Alabama at Birmingham (UAB), USA.
8. Best Paper Award
After a meticulous evaluation, the M&TOD committee honored three outstanding papers with the Best Paper Award in 2023. These notable contributions were granted a total bonus of US$2,300 for their exceptional quality and impact:
(2) The Fatty liver Index (FLI) 15 years later: A reappraisal
9. Journal Partnerships
To further enhance M&TOD’s influence and stay updated with cutting-edge trends, collaborations were established with three international groups and two conferences:
(1) Metabolic fatty liver disease consortium
(2) Asia Pacific Alliance for Obesity and Sarcopenia Metabolism (APAOSM)
(3) Medical Digest congress report
(5) The 21st Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
10. Database
A significant achievement for M&TOD was its successful inclusion in Scopus, accompanied by an impressive CiteScore of 3.2. This milestone marks a crucial advancement in its history.
In its steadfast commitment to disseminating scientific research and fostering innovation in the field of metabolism, M&TOD eagerly anticipates an influx of valuable, high-quality papers and stimulating and insightful discussions. Looking forward to 2024, under the guidance of Editor-in-Chief Prof. Amedeo Lonardo and with the unwavering support from all Editorial Board members, M&TOD is poised to achieve even more remarkable results and exert a greater influence in the scientific community.
Editor: Jennifer Lee
Language Editor: Catherine Yang
Production Editor: Kenny Wu
Respectfully Submitted by the Editorial Office of Metabolism and Target Organ Damage
